Successful treatment with atezolizumab combination chemotherapy in a patient with high‐grade fetal adenocarcinoma of the lung: A case report

Successful treatment with atezolizumab combination chemotherapy in a patient with high‐grade fetal adenocarcinoma of the lung: A case report

Abstract High‐grade fetal lung adenocarcinoma (H‐FLAC) is a rare tumor, with little known of its response to chemotherapy with or without an immune checkpoint inhibitor or of its molecular profile. We report the first case of a 56‐year‐old man with stage IV H‐FLAC who was successfully treated with c...

Full description

Bibliographic Details
Main Authors: Kana Fujimoto, Satomi Watanabe, Yuto Yasuda, Emi Date, Yasuhiro Kawabata, Hiroaki Kanemura, Takayuki Takahama, Kimio Yonesaka, Norishige Iizuka, Ken‐ichi Takahashi, Osamu Kawakami, Tomohiro Ozaki, Kazuhiko Nakagawa
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Thoracic Cancer
Subjects:
atezolizumab
case report
high‐grade fetal lung adenocarcinoma (H‐FLAC)
human epidermal growth factor receptor 2 (HER2, ERBB2)
immunotherapy
Online Access:https://doi.org/10.1111/1759-7714.14768

Internet

https://doi.org/10.1111/1759-7714.14768

Similar Items